Williams-Salmon v. Avanir Pharmaceuticals, Inc.

CourtDistrict Court, N.D. Ohio
DecidedJuly 31, 2020
Docket1:20-cv-00419
StatusUnknown

This text of Williams-Salmon v. Avanir Pharmaceuticals, Inc. (Williams-Salmon v. Avanir Pharmaceuticals, Inc.) is published on Counsel Stack Legal Research, covering District Court, N.D. Ohio primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Williams-Salmon v. Avanir Pharmaceuticals, Inc., (N.D. Ohio 2020).

Opinion

UNITED STATES DISTRICT COURT NORTHERN DISTRICT OF OHIO EASTERN DIVISION MARILYN WILLIAMS-SALMON, ) Case No.: 1:20 CV 419 ) Plaintiff ) JUDGE SOLOMON OLIVER, JR. ) v. ) ) AVANIR PHARMACEUTICALS, ) INC., et al., ) ) Defendants ) ORDER OF REMAND Currently pending before the court in the above-captioned case is Plaintiff Marilyn Williams- Salmon’s (“Plaintiff”) Motion to Remand to State Court (“Motion”) (ECF No. 11). For the reasons that follow, the court grants Plaintiff’s Motion. This case is hereby remanded to the Cuyahoga County Court of Common Pleas from which it was removed. I. BACKGROUND Between 2010 and 2016, Plaintiff received medical treatment from Defendant Deepak Raheja, M.D. (“Dr. Raheja”). (Compl. ¶¶ 78, 80, ECF No. 1-1.) At some point during this treatment, Plaintiff was misdiagnosed with a neurological disorder known as Pseudobulbar Affect (“PBA”). (Id. ¶¶ 6, 86.) Plaintiff maintains that she was unaware of this misdiagnosis until November of 2019, when she was informed by the United States Attorney’s Office (“USAO”) that she was a potential victim of an illegal kickback scheme involving Defendants Dr. Raheja, Gregory Hayslette (“Hayslette”), Frank J. Mazzucco (“Mazzucco”), and relevant to this Motion, Avanir Pharmaceuticals, Inc. (“Avanir”) (collectively, “Defendants”). (Id.) This kickback scheme allegedly involved Avanir and its employees, Hayslette and Mazzucco, providing illegal incentives to Dr. Raheja in exchange for prescribing medications to patients, like Plaintiff, for conditions unsupported

by their presenting symptoms. (Id. ¶¶ 1, 4.) Specifically, Plaintiff contends that she was prescribed a medication called Nuedexta, which is sold by Avanir. (Id. ¶ 6.) Plaintiff maintains that she suffered numerous personal injuries as a result of Defendants’ conduct. (Id. ¶ 7.) On January 21, 2020, Plaintiff commenced this action in the Cuyahoga County Court of Common Pleas alleging various state law claims against Defendants. (Compl., ECF No. 1-1.) In the Complaint, Plaintiff brought the following claims: medical malpractice against Dr. Raheja (“Count One”); medical battery and lack of informed consent against Dr. Raheja (“Count Two”); negligence against all Defendants (“Count Three”); Civil Recovery for a Criminal Act, Ohio Rev. Code § 2307.60 against all Defendants (“Count Four”); Ohio Corrupt Practices Act, Ohio Rev. Code

§ 2923.34 against all Defendants (“Count Five”); and civil conspiracy against all Defendants (“Count Six”). (Id.) In support of her claims, Plaintiff attached three exhibits to her Complaint: Exhibit A is the federal indictment in United States v. Raheja et al., No. 1:19-CR-559 (N.D. Ohio Sept. 18, 2019), which alleges, among others counts, that Dr. Raheja, Hayslette, and Mazzucco violated the federal Anti-Kickback Statute, 42 U.S.C. § 1320a-7b(b)(1)(B) and 42 U.S.C. § 1320a-7b(b)(2)(B) (the “Federal Indictment”); Exhibit B is the letter that Plaintiff received from the USAO, which informed her of the kickback scheme; and Exhibit C is the Complaint in United States ex rel. Kevin Manieri,

Realtor v. Avanir Pharmaceuticals, Inc. et al., No. 5:15-CV-611 (N.D. Ohio Mar. 27, 2015), which -2- alleges, among other claims, that Avanir violated the federal False Claims Act, 31 U.S.C. § 3729 (the “False Claims Act Complaint”). Plaintiff incorporated the facts and allegations from these Exhibits into her Complaint. (Compl. ¶¶ 11 12, 14, 39 40, ECF No. 1-1.) On February 24, 2020, Avanir removed the case to this court asserting that the court has

jurisdiction under 28 U.S.C. § 1331. (Notice of Removal, ECF No. 1.) Avanir maintains that Plaintiff’s claims arise under federal law and/or implicate substantial federal questions. (Id. ¶ 16.) Alternatively, Avanir contends that should the court determine that it has jurisdiction under § 1331 over less than all of Plaintiff’s claims, it should find that it has supplemental jurisdiction over the remaining claims under 28 U.S.C. § 1367 because Plaintiff’s claims “derive from a common nucleus of operative fact.” (Id. (citing DaimlerChrysler Corp. v. Cuno, 547 U.S. 332, 351 (2006)).) On March 6, 2020, Plaintiff filed the Motion considered herein, requesting the court remand this case to state court, pursuant to 28 U.S.C. § 1447(c). (Mot. at PageID #234, ECF No. 11.) Avanir filed its Opposition (ECF No. 15) on March 20, 2020. On March 27, 2020, Plaintiff filed her Reply.

(ECF No. 17.) II. LEGAL STANDARD Removal from state court to federal court is proper for “any civil action brought in a [s]tate court of which the district courts of the United States have original jurisdiction.” 28 U.S.C. § 1441(a). Federal district courts have original jurisdiction over “federal question” cases, which implicate questions “arising under the Constitution, laws or treaties of the United States.” 28 U.S.C. § 1331. Federal district courts also have original jurisdiction over “civil actions where the amount in controversy exceeds the sum or value of $75,000, exclusive of interest and costs, and is between

… citizens of different states.” 28 U.S.C. § 1332(a). A court considers whether federal jurisdiction -3- existed at the time of removal and the removing party “bear[s] the burden of establishing federal subject-matter jurisdiction.” Ahearn v. Charter Twp. of Bloomfield, 100 F.3d 451, 453 54 (6th Cir. 1996). Pursuant to 28 U.S.C. § 1447(c), “[i]f at any time before final judgment it appears that the district court lacks subject matter jurisdiction, the case shall be remanded.” It is well-settled in the

Sixth Circuit that, “because they implicate federalism concerns, removal statutes are to be narrowly construed.” Long v. Bando Mfg. of Am., Inc., 201 F.3d 754, 757 (6th Cir. 2000). Thus, when there is uncertainty as to whether remand is appropriate, “all doubts should be resolved in favor of remand.” Ethington v. Gen. Elec. Co., 575 F. Supp. 2d 855, 860 (N.D. Ohio 2008). III. LAW AND ANALYSIS Plaintiff asserts that this court lacks federal-question jurisdiction because her Complaint refers only to state law claims and does not raise a substantial question of federal law. (Mem. in Supp. at PageID #236, ECF No. 11-1.) Plaintiff also maintains that because this court lacks original

jurisdiction over any of her claims under 28 U.S.C. § 1331, supplemental jurisdiction under 28 U.S.C. § 1367 is lacking. (Id.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Louisville & Nashville Railroad v. Mottley
211 U.S. 149 (Supreme Court, 1908)
Smith v. Kansas City Title & Trust Co.
255 U.S. 180 (Supreme Court, 1921)
Empire Healthchoice Assurance, Inc. v. McVeigh
547 U.S. 677 (Supreme Court, 2006)
DaimlerChrysler Corp. v. Cuno
547 U.S. 332 (Supreme Court, 2006)
Martin v. Franklin Capital Corp.
546 U.S. 132 (Supreme Court, 2005)
Vaden v. Discover Bank
556 U.S. 49 (Supreme Court, 2009)
Gunn v. Minton
133 S. Ct. 1059 (Supreme Court, 2013)
Chase Manhattan Mortgage Corp. v. Smith
507 F.3d 910 (Sixth Circuit, 2007)
Mikulski v. Centerior Energy Corp.
501 F.3d 555 (Sixth Circuit, 2007)
Ethington v. General Electric Co.
575 F. Supp. 2d 855 (N.D. Ohio, 2008)
Kunzer v. Magill
667 F. Supp. 2d 1058 (D. Minnesota, 2009)
Buddenberg v. Weisdack
109 N.E.3d 1259 (Ohio Supreme Court, 2018)

Cite This Page — Counsel Stack

Bluebook (online)
Williams-Salmon v. Avanir Pharmaceuticals, Inc., Counsel Stack Legal Research, https://law.counselstack.com/opinion/williams-salmon-v-avanir-pharmaceuticals-inc-ohnd-2020.